About
Technology
Issues
FAQ
Links
Official Page
Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.